Impact of Schizophrenia Spectrum Disorders on the Receipt of Invasive and Systemic Therapy for Colorectal Cancer: A Nationwide Multicenter Retrospective Cohort Study in Japan
Acta Psychiatrica Scandinavica · 2026
DOI: 10.1111/acps.70065 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Psychiatrica Scandinavica, 2026. Verfasst von Masaki Fujiwara und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, Medical Development Field, Okayama University, Okayama, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Schizophrenia, Healthcare Disparities. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KAKENHI, Research for Promotion of Cancer Control Programs from the Japanese Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Introduction
This study examined treatment disparities for colorectal cancer among patients diagnosed with schizophrenia spectrum disorders (SSD), focusing on invasive treatments and stage‐appropriate systemic therapy within a universal healthcare system.
Method
In this nationwide retrospective cohort study (2018–2021), we identified 248,966 colorectal cancer patients, including 2337 diagnosed with SSD, using linked cancer registry and insurance claims data in Japan. The presence of SSD was classified according to ICD‐10 codes F20–29. We used multivariable logistic regression to compare the odds of receiving stage‐appropriate adjuvant chemotherapy and systemic therapy, as well as the odds of receiving surgical or endoscopic treatments, between the two groups. The analysis adjusted for age, sex, clinical stage, and scores on the Charlson Comorbidity Index and Barthel Index.
Results
The clinical stage distribution at diagnosis for colorectal cancer differed significantly between patients with SSD and those without psychiatric disorders ( p < 0.001). After adjusting for clinical stage and other covariates, patients with SSD demonstrated significantly lower odds of receiving surgical or endoscopic treatment (adjusted odds ratio [aOR], 0.83; 95% CI, 0.73–0.94). The disparities were more pronounced for systemic therapy; patients with SSD had substantially lower odds of receiving adjuvant chemotherapy for stage III disease (aOR, 0.33; 95% CI, 0.26–0.41) and systemic therapy for stage IV disease (aOR, 0.23; 95% CI, 0.17–0.31).
Conclusion
Patients with SSD encounter substantial disparities in accessing standard colorectal cancer care, particularly systemic therapies. These findings highlight the urgent need for interventions to ensure equitable cancer treatment for this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuropsychiatry, Medical Development Field, Okayama University, Okayama, Japan.
- Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
- Department of Psychiatry, Sekizen Hospital, Tsuyama, Japan.
- Division of Health Services Research, National Cancer Center Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
- Division of Survivorship Research, National Cancer Center Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
ORCID-Profile: Naoki Nakaya, Koji Otsuki, Masatoshi Inagaki
Förderung
- JSPS KAKENHI
- Research for Promotion of Cancer Control Programs from the Japanese Ministry of Health, Labour and Welfare
Zitieren
APA
Fujiwara, M., Yamada, Y., Ishii, T., Watanabe, T., Fujimori, M., Nakaya, N., Kawamura, T., Otsuki, K., Shigeyasu, K., Shimazu, T., Hinotsu, S., Uchitomi, Y., & Inagaki, M. (2026). Impact of Schizophrenia Spectrum Disorders on the Receipt of Invasive and Systemic Therapy for Colorectal Cancer: A Nationwide Multicenter Retrospective Cohort Study in Japan. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.70065
Vancouver
Fujiwara M, Yamada Y, Ishii T, Watanabe T, Fujimori M, Nakaya N, et al. Impact of Schizophrenia Spectrum Disorders on the Receipt of Invasive and Systemic Therapy for Colorectal Cancer: A Nationwide Multicenter Retrospective Cohort Study in Japan. Acta Psychiatrica Scandinavica. 2026. doi:10.1111/acps.70065
BibTeX
@article{Fujiwara2026,
author = {Fujiwara, Masaki and Yamada, Yuto and Ishii, Taisuke and Watanabe, Tomone and Fujimori, Maiko and Nakaya, Naoki and Kawamura, Toshihiko and Otsuki, Koji and Shigeyasu, Kunitoshi and Shimazu, Taichi and Hinotsu, Shiro and Uchitomi, Yosuke and Inagaki, Masatoshi},
title = {Impact of Schizophrenia Spectrum Disorders on the Receipt of Invasive and Systemic Therapy for Colorectal Cancer: A Nationwide Multicenter Retrospective Cohort Study in Japan},
journal = {Acta Psychiatrica Scandinavica},
year = {2026},
doi = {10.1111/acps.70065}
}
EUVIMED